Global Synbiotic Market Size (2024-2030)
In 2023, the Global Synbiotic Market witnessed a valuation of $0.95 billion, and it is anticipated to achieve a market size of $1.56 billion by 2030. The market is poised to expand at a CAGR of 8.7% during the forecast period spanning from 2024 to 2030. The upsurge in the utilization of synbiotics across diverse sectors including food & beverages, pharmaceuticals, and animal feed, driven by their diverse nutritional and health benefits, is steering the market growth.
Overview of the Synbiotic Market
Synbiotics, a synergistic blend of prebiotics and probiotics, foster the proliferation and survival of gut bacteria predominantly inhabiting the human gastrointestinal tract's intestines and colon. They were formulated to tackle the challenges encountered by probiotics within the stomach. Consequently, a product comprising an optimal amalgamation of both prebiotic and probiotic elements is expected to elicit a more favorable impact compared to the impact of either component in isolation. These products are available both as dietary supplements and food items. Synbiotics offer a range of nutritional and physiological benefits including enhanced weight loss, mental acuity, digestive health, cardiovascular well-being, improved immune function, reduced inflammation, and decreased susceptibility to cardiovascular diseases. Additionally, they are employed in addressing hepatic conditions and augmenting the absorption of essential minerals such as calcium, phosphorus, and magnesium. In aquaculture, they are utilized to bolster fish output by fortifying the immune system. Furthermore, the fortification of dairy products and meals with synbiotics has surged to deliver nutritional and health advantages, thereby propelling the synbiotic market forward.
Companies within the food and beverage sector, alongside other industries, are integrating functional ingredients such as probiotics, prebiotics, and synbiotics into their product portfolios to offer nutritional enrichment and other health benefits. Synbiotics are anticipated to witness an escalating demand in the supply chain, owing to their utilization in pet food and pharmaceutical sectors, coupled with the growing significance of fibers within the food and beverage industry. The demand for functional foods has surged in response to deteriorating health conditions among the populace. Moreover, the burgeoning dairy sector in countries like India and China is poised to bolster the growth of the synbiotic market in the forthcoming years. However, the high cost associated with synbiotics, alongside inadequate awareness regarding their benefits, might impede the future expansion of the synbiotic market. Nevertheless, the escalating loss of aquaculture species is projected to elevate the demand for feed items, thereby fueling the expansion of the synbiotic market.
Impact of COVID-19 on the Synbiotic Market
The outbreak of the COVID-19 pandemic has spurred the demand for synbiotic products. Individuals encountered significant gastrointestinal issues as a consequence of the infection, thereby amplifying the demand for prebiotics and probiotics. Subsequent to the challenges posed by the Covid crisis, a plethora of new products emerged to cater to the surging need for synbiotics. With the economic resurgence witnessed across numerous emerging nations, the market for Synbiotic Products is swiftly approaching pre-COVID levels, exhibiting a robust growth trajectory anticipated for the projected period. However, the prospect of imminent third and subsequent waves presents unprecedented challenges.
Market Drivers
Rapidly Growing Health-Conscious Consumer Base
The market is expanding owing to the exponential rise in health-conscious consumers. Recent years have witnessed a substantial surge in health-conscious consumers globally, alongside a proliferation of products based on prebiotics and postbiotics. These components facilitate nutrient production and enhance their bioavailability; certain probiotics, in the form of intact cells or lysates, exhibit antioxidative properties. Probiotics have demonstrated efficacy in alleviating allergy symptoms, cancer, AIDS, lung infections, and urinary tract infections. Limited studies also suggest their potential benefits in anti-aging, fatigue mitigation, autism, osteoporosis, obesity, and type 2 diabetes management. Synbiotics play a pivotal role in diarrhoea management. Extensive research conducted by the World Health Organization (WHO) over the past decade on probiotic microorganisms, encompassing in vitro studies, animal trials, and meticulously designed clinical studies, has corroborated the advantageous effects of probiotic intake in alleviating various forms of diarrhea.
Growing Awareness Regarding the Nutritional Advantages of Synbiotics
Synbiotics represent a class of nutrient-rich foods delivering sustained digestive health benefits. Probiotic strains integrated into synbiotic formulations comprise Lactobacilli, Bifidobacteria, S. boulardii, and Bifidobacteriumcoagulans, while oligosaccharides such as fructooligosaccharide and xyloseoligosaccharide, alongside inulin, are sourced from natural reservoirs such as chicory and yacon roots. According to the National Center for Biotechnology Information, an estimated 62 million Americans grapple with digestive disorders. The prevalence of most digestive ailments tends to escalate with advancing age. The consumption of synbiotics has been associated with increased levels of lactobacilli and bifidobacteria, a balanced gut microbiota, enhanced liver function among cirrhotic patients, bolstered immunomodulatory capabilities, prevention of bacterial translocation, and reduced nosocomial infections, particularly among surgical patients.
Market Restraints
Anticipated Market Contraction Due to the High Price Range of Synbiotics
The market expansion of synbiotics is expected to encounter obstacles due to the high production costs associated with these products. The repercussions of the global spread of COVID-19 have resulted in diminished utilization and volatility within the supply chains of retail items for food and beverage companies. Synbiotic manufacturers have curtailed their production capacities owing to shortages in raw materials and a shortfall in manpower. The global synbiotic market has experienced contractions owing to disruptions in the production and supply chains of food, beverage, and pharmaceutical products.
Lack of Awareness Regarding Synbiotics Hindering Market Growth
A notable impediment thwarting market growth is the lack of awareness among the general populace regarding the nutritional benefits offered by synbiotic products, particularly evident in developing regions such as Africa and the Middle East.
SYNBIOTIC MARKET– BY PRODUCT OUTLOOK
In terms of product outlook, the synbiotic market exhibits segmentation into Functional Food & Beverages, Dietary Supplements, and Animal Feeds, among other categories. Leading the market in 2020, Functional Food & Beverages accounted for 84.1% of the market share and is anticipated to expand at a CAGR of over 9% during the forecast period. The forthcoming years are expected to witness a surge in the use of functional foods and beverages for enhancing immunity, cardiac health, and digestive well-being, thereby opening new avenues for synbiotic products in the market. Collaborations between food giants such as Nestle and Pfizer with academic institutions, aimed at understanding the impact of the microbiome on human health, are indicative of the evolving landscape. For instance, in November 2019, Nestlé unveiled a partnership with the University of California San Diego's Center for Microbiome Innovation (CMI) to deepen its comprehension of how the microbiome influences human health and to foster the development of health-promoting nutritional solutions.
The Dietary Supplements category is forecasted to experience the fastest growth from 2024 to 2030, with a CAGR of 9.6%. The escalating demand for synbiotic-based dietary supplements can be attributed to heightened consumer awareness and extensive marketing efforts. Additionally, these nutritional supplements boast advantages such as lower calorie content compared to dairy products, prolonged shelf life, and no refrigeration requirement. They also serve as an optimal choice for individuals with lactose intolerance, thereby propelling the demand for synbiotic-based dietary supplements in the forthcoming years.
SYNBIOTIC MARKET– BY FORM
The synbiotic market is categorized by form into Capsules, Powder, and Liquid, with capsules emerging as the most preferred option owing to their ease of availability and transportation convenience.
SYNBIOTIC MARKET- BY DISTRIBUTION CHANNEL
In terms of distribution channels, the synbiotic market delineates between Offline and Online Stores. The year 2020 witnessed the dominance of offline distribution channels, holding a substantial 93.3% share in the market for synbiotic products. The widespread availability of synbiotic items in retail and pharmacy outlets significantly bolstered offline sales. In the forthcoming years, the increasing number of stores in burgeoning markets such as India, China, and Brazil is poised to positively impact this segment's growth trajectory. Notably, as of May 2018, Walmart operated 21 stores in India, with plans for an additional 50 by the close of 2024.
From 2020 to 2030, the online distribution channel is anticipated to emerge as the fastest-growing segment, exhibiting a robust CAGR of 10.6%. The escalating reliance on the internet and e-commerce platforms among Generation X, millennials, and Generation Z parents is expected to propel synbiotic product sales through online channels in the coming years. The foreseeable future also holds promise for online channels due to value-added services provided by e-retailers, including discounted pricing, cash-on-delivery options, and rewards programs. This channel encompasses both aggregators and manufacturer-hosted e-commerce platforms. Manufacturers, recognizing the channel's potential, are establishing their e-commerce websites to better cater to customer needs and drive profit margins.
SYNBIOTIC MARKET- BY REGION
The Synbiotic Market is geographically segmented into North America, Europe, Asia Pacific, Latin America, The Middle East, and Africa. Europe emerged as the frontrunner in 2021, capturing a substantial 40% share of the regional market. Following Europe, North America and the Asia-Pacific regions showcased significant market presence. The market's growth in Europe can be attributed to heightened awareness of synbiotic products, driven by the escalating demand for functional foods and their widespread visibility. The persistent need for prebiotics and probiotics in food formulations, coupled with a robust manufacturing base for food and beverage producers, presents lucrative opportunities for the incorporation of synbiotics in various products across the region. Furthermore, the European Union's emphasis on clear labeling for foods making nutritional or health claims has spurred the utilization of synbiotic properties in diverse formulations across the region.
The Asia Pacific region is projected to witness a robust CAGR of 9.5% over the forecast period. The trend of dining out is on the rise, potentially impacting intestinal health adversely. The growing adoption of probiotics and prebiotics for treating digestive disorders and ulcerative colitis is expected to be a key driver for the regional synbiotic market.
SYNBIOTIC MARKET- BY COMPANIES
Given the presence of significant regional and local competitors across various countries, the global synbiotic products market is characterized by fragmentation and competitiveness. Prominent corporations employ strategic techniques such as mergers, expansions, acquisitions, partnerships, and new product developments to enhance their brand visibility among consumers. Some key players operating in the Synbiotic market comprise:
NOTABLE EVENTS IN THE SYNBIOTIC MARKET
Chapter 1. SYNBIOTIC MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. SYNBIOTIC MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. SYNBIOTIC MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. SYNBIOTIC MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5.SYNBIOTIC MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. SYNBIOTIC MARKET– BY PRODUCT OUTLOOK
6.1. Functional Food & Beverages
6.2. Dietary Supplements
6.3. Animal Feeds
6.4. Other
Chapter 7. SYNBIOTIC MARKET– BY FORM
7.1. Capsules
7.2. Powder
7.3. Liquid
Chapter 8. SYNBIOTIC MARKET– By DISTRIBUTION CHANNEL
8.1. Offline Stores
8.2. Online Stores
8.3. Others
Chapter 9. SYNBIOTIC MARKET– By Region
9.1. North America
9.2. Europe
9.3.The Asia Pacific
9.4.Latin America
9.5. Middle-East and Africa
Chapter 10. SYNBIOTIC MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Daflorn Ltd.
10.2 . Hansen A/S
10.3. SKYSTONE FEED CO.
10.4. LTD, BEHN MEYER
10.5. Yakult Pharmaceutical Industry Co., Ltd.
10.6. Pfizer Inc.
10.7. Ajinomoto Co., Inc.
10.8. Calpis Co., Ltd.
10.9. Danone
10.10. Morinaga & Company Ltd
2850
5250
4500
1800